Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBR SystemsEBRCZ -13.33%22 EV-to-EBIT is -3.35 as of Jul. 27, 2026. GuruFocus rates EBRCZ with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 466 Medical Devices & Instruments companies, EBR Systems ranks worse than 214592.06% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
EBR Systems's Enterprise Value for the quarter that ended in Mar. 2026 was $227.92 Mil.
EBR Systems's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-49.71 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBR Systems EV-to-EBIT Related Terms
EBR Systems EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for EBR Systems's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, EBR Systems's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EBR Systems EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EBR Systems's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where EBR Systems's EV-to-EBIT falls into.
EBR Systems's current Enterprise Value is $166.55 Mil.
EBR Systems's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-49.71 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBR Systems (EBRCZ) has a EV-to-EBIT of -3.35 as of Jul. 27, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EBR Systems and its competitors. According to the industry distribution chart, EBR Systems ranks #999999 out of 466 companies in the Medical Devices & Instruments industry.
Is EBR Systems' EV-to-EBIT too high?
EBR Systems' current EV-to-EBIT is -3.35. Based on the distribution chart, EBR Systems ranks #999999 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, EBR Systems has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does EBR Systems' EV-to-EBIT compare to OWLT and APYX?
According to the Medical Devices & Instruments industry distribution chart, EBR Systems ranks #999999 out of 466 companies for EV-to-EBIT. This places EBR Systems in the lower half of its industry. The industry median EV-to-EBIT is 18.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.40, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EBR Systems and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EBR Systems's current EV-to-EBIT is -3.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EBR Systems stock overvalued right now?
EBR Systems (EBRCZ) has a current EV-to-EBIT of -3.35. The current EV-to-EBIT is -3.35. EBR Systems' overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For EBR Systems (EBRCZ), the current EV-to-EBIT is -3.35 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EBR Systems Inc is engaged in treatment for patients suffering from cardiac rhythm diseases by developing therapies using wireless cardiac stimulation. The company's Wise CRT System uses proprietary wireless technology to deliver pacing stimulation directly inside the left ventricle of the heart. It conducts its operations in the United States.
22GF Score
Get the complete analysis for EBRCZ
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EBRCZ has been successfully added to your 
